
Ruth A. Davis
Examiner (ID: 17567, Phone: (571)272-0915 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1699 |
| Total Applications | 1627 |
| Issued Applications | 799 |
| Pending Applications | 220 |
| Abandoned Applications | 618 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18018978
[patent_doc_number] => 20220370477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => Solid Oral Dosage Forms Of Dexamethasone
[patent_app_type] => utility
[patent_app_number] => 17/742843
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742843 | Solid Oral Dosage Forms Of Dexamethasone | May 11, 2022 | Abandoned |
Array
(
[id] => 19345120
[patent_doc_number] => 20240254083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => HETEROCYCLIC TRPML1 AGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/559288
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -95
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559288
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559288 | HETEROCYCLIC TRPML1 AGONISTS AND USES THEREOF | May 10, 2022 | Pending |
Array
(
[id] => 19263559
[patent_doc_number] => 20240207256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/560312
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560312
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/560312 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | May 10, 2022 | Pending |
Array
(
[id] => 19464027
[patent_doc_number] => 20240317696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => ALKYL CARBOXYLIC ACID COMPOUNDS AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/559968
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559968
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559968 | ALKYL CARBOXYLIC ACID COMPOUNDS AND APPLICATION THEREOF | May 9, 2022 | Pending |
Array
(
[id] => 19316776
[patent_doc_number] => 20240238316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => CANNABINOID POUCH
[patent_app_type] => utility
[patent_app_number] => 18/559293
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559293 | CANNABINOID POUCH | May 9, 2022 | Pending |
Array
(
[id] => 19359258
[patent_doc_number] => 20240261292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => COMBINATION THERAPIES
[patent_app_type] => utility
[patent_app_number] => 18/560233
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 349
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560233
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/560233 | COMBINATION THERAPIES | May 8, 2022 | Pending |
Array
(
[id] => 17805699
[patent_doc_number] => 20220257534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => NAIL HARDENING COMPOSITION AND METHOD OF US
[patent_app_type] => utility
[patent_app_number] => 17/739099
[patent_app_country] => US
[patent_app_date] => 2022-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739099 | Nail hardening composition and method of use | May 6, 2022 | Issued |
Array
(
[id] => 19403551
[patent_doc_number] => 20240287062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => NAPHTHYRIDONE COMPOUNDS FOR INHIBITION OF RAF KINASES AND/OR BCR-ABL TYROSINE KINASES
[patent_app_type] => utility
[patent_app_number] => 18/559317
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559317
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559317 | NAPHTHYRIDONE COMPOUNDS FOR INHIBITION OF RAF KINASES AND/OR BCR-ABL TYROSINE KINASES | May 5, 2022 | Pending |
Array
(
[id] => 20730166
[patent_doc_number] => 12637413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/558726
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 10759
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558726
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/558726 | Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors | May 5, 2022 | Issued |
Array
(
[id] => 18932207
[patent_doc_number] => 11884613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Processes and intermediates for the preparation of carbaprostacyclin analogues
[patent_app_type] => utility
[patent_app_number] => 17/737273
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16764
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737273
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737273 | Processes and intermediates for the preparation of carbaprostacyclin analogues | May 4, 2022 | Issued |
Array
(
[id] => 17851781
[patent_doc_number] => 20220281823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => PHENYL AND PYRIDINYL SUBSTITUTED IMIDAZOLES AS MODULATORS OF RORgT
[patent_app_type] => utility
[patent_app_number] => 17/737113
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737113 | PHENYL AND PYRIDINYL SUBSTITUTED IMIDAZOLES AS MODULATORS OF RORgT | May 4, 2022 | Abandoned |
Array
(
[id] => 17807334
[patent_doc_number] => 20220259169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => MULTI-STAGE ESTERIFICATION PROCESS
[patent_app_type] => utility
[patent_app_number] => 17/737408
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737408 | MULTI-STAGE ESTERIFICATION PROCESS | May 4, 2022 | Abandoned |
Array
(
[id] => 19325972
[patent_doc_number] => 12043637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing
[patent_app_type] => utility
[patent_app_number] => 17/736688
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 20367
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736688 | Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing | May 3, 2022 | Issued |
Array
(
[id] => 17837636
[patent_doc_number] => 20220274941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PROCESS FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID DIALKYL ESTER
[patent_app_type] => utility
[patent_app_number] => 17/736644
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736644
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736644 | PROCESS FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID DIALKYL ESTER | May 3, 2022 | Abandoned |
Array
(
[id] => 19299898
[patent_doc_number] => 20240228467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => INDIRUBIN COMPOUNDS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/557800
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557800
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557800 | INDIRUBIN COMPOUNDS AND METHODS THEREOF | Apr 28, 2022 | Pending |
Array
(
[id] => 19360774
[patent_doc_number] => 20240262808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => XANTHINE OXIDASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/557919
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557919
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557919 | XANTHINE OXIDASE INHIBITOR | Apr 27, 2022 | Pending |
Array
(
[id] => 19299922
[patent_doc_number] => 20240228491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/557795
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557795
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557795 | METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Apr 27, 2022 | Pending |
Array
(
[id] => 20100204
[patent_doc_number] => 20250230140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-17
[patent_title] => NOVEL TRIAZOLE-PYRIDINE SUBSTITUTED PYRROLIDINYL AND TETRAHYDRO-2H-PYRANYL ACETIC ACID COMPOUNDS AS LPA ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/557918
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557918
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557918 | NOVEL TRIAZOLE-PYRIDINE SUBSTITUTED PYRROLIDINYL AND TETRAHYDRO-2H-PYRANYL ACETIC ACID COMPOUNDS AS LPA ANTAGONISTS | Apr 27, 2022 | Pending |
Array
(
[id] => 19528099
[patent_doc_number] => 20240352001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF XANTHINE OXIDASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/557786
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557786
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557786 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF XANTHINE OXIDASE INHIBITOR | Apr 25, 2022 | Pending |
Array
(
[id] => 20438606
[patent_doc_number] => 12509433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Process for the production of furfural using a water immiscible organic solvent
[patent_app_type] => utility
[patent_app_number] => 17/729287
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4800
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729287
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/729287 | Process for the production of furfural using a water immiscible organic solvent | Apr 25, 2022 | Issued |